In this episode of Meeting Mic, we bring you pearls and perspectives from the American Society of Retina Specialists Annual Meeting.

In an interview, Anat Loewenstein, MD, MHA, of Tel Aviv Medical Center, talks about how Home OCT combined with an AI analysis helped in the early detection of retinal fluid in patients with age-related macular degeneration.

Next, David Almeida, MD, MBA, PhD, of Erie Retina Research in Pennsylvania, talks about how CG-P5, a topical peptide eye drop, met safety and efficacy endpoints for wet age-related macular degeneration.

Hasenin Al-khersan, MD, discusses findings from a retrospective study on pegcetacoplan slowing photoreceptor and retinal pigment epithelium loss in patients with geographic atrophy only as well as patients with GA and concurrent wet age-related macular degeneration.

Sunir J. Garg, MD, FACS, FASRS, discusses findings from a real-world study about suprachoroidal triamcinolone acetonide having a durable effect in patients with chronic cystoid macular edema.

And, Christina Y. Weng, MD, MBA, FASRS, of Baylor College of Medicine in Houston tells us about her study on systemic statin use reducing the rate of proliferative vitreoretinopathy and reoperation following primary retinal detachment repair by nearly half.

Read the full coverage here:

Home OCT with AI comparable to expert graders in AMD

Loewenstein A. Longitudinal performance of a trend analysis algorithm for home OCT monitoring in neovascular age-related macular degeneration (NVAMD). Presented at: American Society of Retina Specialists annual meeting; July 15-18, 2026; Montreal.

Peptide eye drop shows fluid, thickness reductions in patients with wet AMD

Almeida D, et al. Efficacy and safety of a novel topical peptide (CG-P5) for the treatment of neovascular age-related macular degeneration: Phase 1 results. Presented at: American Society of Retina Specialists annual meeting; July 15-18, 2026; Montréal, Canada

Pegcetacoplan slows photoreceptor, RPE loss in patients with GA and concurrent wet AMD

Al-khersan H. Assessment of geographic atrophy progression following pegcetacoplan in the real world with and without neovascular age-related macular degeneration. Presented at: American Society of Retina Specialists annual meeting; July 15-18, 2026; Montreal.

Suprachoroidal triamcinolone shows durable effect in cystoid macular edema

Garg SJ, et al. Durability and safety of suprachoroidal triamcinolone acetonide in eyes with chronic cystoid macular edema in real-world clinical practice. Presented at: American Society of Retina Specialists annual meeting; July 15-18, 2026; Montreal.

Study: Statin use halves risk for PVR after retinal detachment surgery

Weng CY, et al. Statin use and association with proliferative vitreoretinopathy and reoperation risk following retinal detachment surgery. Presented at: American Society of Retina Specialists annual meeting; July 15-18, 2026; Montreal.

Al-khersan reports consulting for Apellis. Almeida reports being a researcher and consultant for Caregen. Garg reports consulting for Bausch + Lomb. The study was funded by Bausch + Lomb. Loewenstein reports consulting for Notal Vision. Weng reports no relevant financial disclosures.